SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Zhong H, Lu W, Tang Y, Wiel C, et al. Oncogene 2023;42:2183-2194.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhong H, Lu W, Tang Y, Wiel C, et al. SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Oncogene 2023;42:2183-2194.
PMID: 37258742